Drug Trial Radar · NCT05862272
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Last checked: Nov 19, 2026Latest source record: Aug 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Aug 14, 2023
Primary completion
Jul 2029
Study completion Sep 2030
Sponsor
- Lead sponsor
- Sumitomo Pharma Switzerland GmbHIndustry
- Sponsor type
- Industry
- First posted
- May 17, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with heavy menstrual bleeding associated with uterine leiomyomas (fibroids) or with moderate-to-severe pain associated with endometriosis.
Conditions
- Uterine Fibroids
- Endometriosis
Interventions
Relugolix Combination TabletDrug
A fixed-dose combination tablet containing relugolix 40 mg, estradiol (E2) 1 mg, and norethindrone acetate (NETA) 0.5 mg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in BMD (bone mineral density) at Month 48 on-treatment at lumbar spine (L1-L4) in women with uterine fibroids.Time frame: Baseline up to Month 48
- Percent change from baseline in BMD at Month 48 on-treatment at lumbar spine (L1-L4) in women with endometriosis.Time frame: Baseline up to Month 48
Locations
120 sites in 1 country. Site status is shown where the registry gives one.
Mobile
Mobile, Alabama · Recruiting
Chandler
Chandler, Arizona · Recruiting
Mesa
Mesa, Arizona · Recruiting
Peoria
Peoria, Arizona · Recruiting
Phoenix
Phoenix, Arizona · Recruiting
Tucson
Tucson, Arizona · Recruiting
Burbank
Burbank, California · Recruiting
Canoga Park
Canoga Park, California · Recruiting
Encinitas
Encinitas, California · Recruiting
Inglewood
Inglewood, California · Recruiting
Lomita
Lomita, California · Recruiting
Long Beach
Long Beach, California · Recruiting
Los Angeles
Los Angeles, California · Recruiting
Sacramento
Sacramento, California · Recruiting
San Fernando
San Fernando, California · Recruiting
Stanford
Stanford, California · Recruiting
Valley Village
Valley Village, California · Recruiting
Aurora
Aurora, Colorado · Recruiting
Greenwood Village
Greenwood Village, Colorado · Recruiting
Lakewood
Lakewood, Colorado · Recruiting
Washington
Washington D.C., District of Columbia · Recruiting
Aventura
Aventura, Florida · Recruiting
Deland
DeLand, Florida · Recruiting
Hialeah
Hialeah, Florida · Recruiting
Kissimmee
Kissimmee, Florida · Recruiting
Lake Worth
Lake Worth, Florida · Recruiting
Margate
Margate, Florida · Recruiting
Miami
Miami, Florida · Recruiting
Miami
Miami, Florida · Recruiting
Miami
Miami, Florida · Recruiting
Miami Beach
Miami Beach, Florida · Recruiting
Miami Springs
Miami Springs, Florida · Recruiting
New Port Richey
New Port Richey, Florida · Recruiting
New Port Richey
New Port Richey, Florida · Recruiting
Orlando
Orlando, Florida · Recruiting
Orlando
Orlando, Florida · Recruiting
Panama City
Panama City, Florida · Recruiting
Sarasota
Sarasota, Florida · Recruiting
Tamarac
Tamarac, Florida · Recruiting
Tampa
Tampa, Florida · Recruiting
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.